Feature | June 23, 2010

The Benefits of Transradial Access

Radial access is very popular outside the United States because it offers improved safety, comfort and cost savings over femoral access, which is the current U.S. standard of care. Femoral access site recovery usually involves heavy, uncomfortable compression of the leg. Patients are also required to lay on their back, in bed and not move for hours to ensure proper hemostasis. These discomforts are eliminated with radial access.

Most importantly, the risk of bleeding and arterial damage, the most common complications following these procedures, is essentially eliminated with the transradial approach, said Jack P. Chen, M.D., FACC, FSCAI, FCCP, director of cardiac research, St. Joseph’s Translational Research Institute, Saint Joseph’s Heart and Vascular Institute, Atlanta. He also directs a course to train cardiologists on the transradial technique.

“If you talk to any patient who has gone through a transfemoral procedure, they will tell you the worst thing is after the procedure. That’s what patients dread the most,” Chen told Diagnostic and Invasive Cardiology. “Most patients complain of the bed rest, the back pain, muscle spasms and the tremendous amount of pressure applied to their groin by a clamp or a staff member. You can spend three hours performing a complex, multidevice, multivessel bifurcation rotablator/stent case with an excellent result, but what the patient will remember is the pain from the pseudoaneurysm repair they now need.”
Radial access eliminates this vascular access risk, as well as the pain and discomfort associated with hours of bed rest, Chen said. “There is no question patients prefer this,” Chen explained.

With patients who have undergone both radial and femoral access procedures, Chen said the vast majority will never let him touch their legs again. This type of patient satisfaction has spread by word of mouth and has led to an increasing number of patients seeking radial access procedures at St. Joseph’s. “My patients are the procedure’s and my best advocates,” Chen said.

In March 2010, St. Joseph's Hospital of Atlanta opened the first transradial access recover lounge in the United States. It replaces beds with chairs and patients are encouraged to walk around, get coffee, check their e-mail and read.

Related Content

TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o
htisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) and chief, Division of Cardiovascular Medicine at UC San Diego Medical Center,
Podcast | Cath Lab | May 13, 2020
This podcast is an interview with Ehtisham Mahmud, M.D., FSCAI, president of the Society for Cardiovascular Angiograp
Nuance Communications Inc. introduced Nuance Cardiovascular CAPD, a new computer-assisted physician documentation (CAPD) solution designed to help cardiologists improve the quality of complex documentation and the accuracy of reimbursement for cardiac catheterization procedures. The Nuance Cardiovascular CAPD solution is available through a partnership with ZHealth for this solution, which is based on patented algorithms built with ZHealth’s interventional documentation and coding expertise.
News | Cath Lab | January 31, 2020
January 29, 2020 – Nuance Communications Inc.
Videos | Cath Lab | January 09, 2020
Haval Chweich, M.D., medical director of the cardiac critical care unit (CCU) at Tufts Medical Center, and assistant...
People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.  In early December 2019, leaders of the European Association for Cardiothoracic Surgery (EACTS) withdrew their support for European practice guidelines that endorse the use of coronary stents in many patients with left main coronary artery disease.

People watch the live presentation of the five-year EXCEL Trial data by Gregg Stone, M.D., in the Abbott booth at TCT 2019. Abbott makes the Xience stent used in the trial, which compared equally with long-term CABG surgical outcomes.

News | Cath Lab | January 02, 2020 | Dave Fornell, Editor
January 2, 2020 — In early December 2019, leaders of the European As...